EUCTR2005-002208-40-IT进行中（未招募）不适用
evetiracetam Keppra in the dyskinesias induced from levodopa in patients with disease of Parkinson. Clinical study pilot in open, with farmacokinetic-farmacodynamic monitoring of the effects.
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI0 个研究点目标入组 12 人开始时间: 2006年2月7日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
: The Role of Keppra in the Treatment of Tremor in Multiple SclerosisMultiple SclerosisEUCTR2005-003903-35-GBewcastle-upon-Tyne Hospitals NHS Trust20
已完成
2 期
evetiracetam (Keppra®) in neonatesNL-OMON30449Erasmus MC, Universitair Medisch Centrum Rotterdam10
进行中（未招募）
不适用
evetiracetam (Keppra®) in neonatesepileptic seizures in neonates admitted to the intensive care unitMedDRA version: 9.1Level: LLTClassification code 10041350Term: Somnolence neonatalMedDRA version: 9.1Level: LLTClassification code 10013573Term: DizzinessMedDRA version: 9.1Level: LLTClassification code 10004210Term: Behavioural disorderEUCTR2006-006804-12-NLErasmusMedical Center-Sophia
已完成
2 期
Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron DiseaseAmyotrophic Lateral SclerosisPrimary Lateral SclerosisProgressive Muscular AtrophyMotor Neuron DiseaseNCT00324454Duke University20
已完成
不适用
The Effect of Levetiracetam (Keppra) on the Treatment of Tremor in Multiple SclerosisMultiple SclerosisNCT00430599Newcastle-upon-Tyne Hospitals NHS Trust20